- জেনেরিক নাম
- Pirfenidone
- শক্তি
- 801 mg
- ডোজ ফর্ম
- Tablet
- প্রস্তুতকারক
- Opsonin Pharma Limited
৳ ১২২.৫ ৳ ১২৫ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৬ Nov ২০২৬
বাংলাদেশে Pulbo 801 mg Tablet ট্যাবলেট হিসেবে পাওয়া যায়; এতে Pirfenidone আছে (৮০১ mg)। Pulbo 801 mg-এর সাথে Pirfenidone-এর অন্য ব্র্যান্ডের দাম নিচে তুলনা করে দেখুন। Pulbo 801 mg-এর প্রতি ইউনিটের দাম ১২৫ টাকা। Pulbo 801 mg প্রস্তুত করেছে Opsonin Pharma Limited। এই তথ্য শুধু জানার জন্য; ঔষধ সবসময় ডাক্তারের পরামর্শ অনুযায়ী খাবেন, মাত্রা বা ব্র্যান্ড নিয়ে প্রশ্ন থাকলে ফার্মাসিস্টকে জিজ্ঞেস করুন।
Pirfenidone-এর ৯টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। এর চেয়ে কম ইউনিট দামের ব্র্যান্ড আছে ১টি। সবচেয়ে কম দাম Pulbo 267 mg Capsule-এর, প্রতি ইউনিট ৳ ৪৫।
Pulbo 801 mg 801 mg is a tablet product of Opsonin Pharma Limited that contains Pirfenidone. The doctor sets the dose and course. The tablet strength shown is 801 mg. Ask your doctor or pharmacist if you are unsure about it.
Pirfenidone, the active ingredient, is an immunosuppressant that is thought to reduce some of the processes involved in scarring. Only a specialist physician experienced in diagnosing and treating IPF should start and supervise this treatment. Ask your doctor whether it is right for your condition.
Treatment must be started and supervised by a specialist physician experienced in IPF, and the doctor decides your dose and course, including any step-by-step adjustment when treatment begins. Swallow the tablet with water. Pulbo 801 mg is taken by mouth. If you miss a dose, ask your doctor or pharmacist what to do.
Like all medicines, Pulbo 801 mg can cause side effects. Seek medical advice promptly if a reaction is severe, does not settle, or worries you. Commonly reported ones in studies include nausea, rash, tiredness, diarrhoea, indigestion and increased sensitivity of the skin to sunlight. Do not stop the medicine on your own; the doctor will advise what to do. Tell your doctor if these or any other unusual symptoms appear, and do not ignore them.
Before taking Pulbo 801 mg, tell your doctor about any health problems you have, especially liver or kidney problems, and about all other medicines you take. This medicine must not be used with fluvoxamine, and it is not for people with severe liver impairment or end-stage liver disease, or severe kidney impairment or end-stage kidney disease needing dialysis. Pregnancy: there are no data in pregnant women, and as a precaution it is preferable to avoid use during pregnancy. Ask your doctor first if any of these apply to you.
Pirfenidone, the active ingredient, is an immunosuppressant that is thought to reduce some of the processes involved in scarring. Only a specialist physician experienced in diagnosing and treating IPF should start and supervise this treatment.
Treatment must be started and supervised by a specialist physician experienced in IPF, and the doctor decides your dose and course, including any step-by-step adjustment when treatment begins. Swallow the tablet with water.
Like all medicines, Pulbo 801 mg can cause side effects. Seek medical advice promptly if a reaction is severe, does not settle, or worries you.
Before taking Pulbo 801 mg, tell your doctor about any health problems you have, especially liver or kidney problems, and about all other medicines you take. This medicine must not be used with fluvoxamine, and it is not for people with severe liver impairment or end-stage liver disease, or severe kidney impairment or end-stage kidney disease needing dialysis.
৳ ১২২.৫ ৳ ১২৫ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৬ Nov ২০২৬
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pirfenidone is indicated in adults for the treatment of mild to moderate Idiopathic Pulmonary Fibrosis (IPF).এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pirfenidone is an orally active, small molecule that shows a wide range of biologic activity. In vitro evidence has shown that pirfenidone inhibits collagen synthesis, down-regulates profibrotic cytokines and decreases fibroblast proliferation. Pirfenidone leads to a reduction of TGF-beta2 mRNA levels and of the mature TGF-beta2 protein due to decreased expression and direct inhibition of the TGF-beta pro-protein convertase furin. In addition, pirfenidone reduces the protein levels of the matrix metalloproteinase (MMP)-11, a TGF-beta target gene and furin substrate involved in carcinogenesis.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Treatment with Pirfenidone should be initiated and supervised by specialist physicians experienced in the diagnosis and treatment of IPF. Upon initiating treatment, the dose should be titrated to the recommended daily dose of nine 267 mg tablets or one 801 mg tablet per day over a 14-days period for adult as follows:এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Hypersensitivity to the active substance or to any of the excipients, concomitant use of fluvoxamine, severe hepatic impairment or end stage liver disease, severe renal impairment (CrCl <30 ml/min) or end stage renal disease requiring dialysis.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
The safety of Pirfenidone has been evaluated in clinical studies including 1345 healthy volunteers and patients. The most commonly reported (10%) adverse reactions during clinical study experience with Pirfenidone at a dose of 2403 mg/day compared to placebo, respectively, were nausea (32.8% versus 13.3%), rash (28.7% versus 8.6%), fatigue (22.3% versus 13.3%), diarrhoea (21.7% versus 13.5%), dyspepsia (16.8% versus 5.5%), and photosensitivity reaction (12.2% versus 1.7%). Serious adverse reactions were recorded at similar frequencies among patients treated with 2403 mg/day of Pirfenidone and placebo in clinical studies. The adverse reactions reported at a frequency of 2% in 345 patients receiving Pirfenidone at the recommended dose of 2403 mg/day in two pivotal Phase 3 studies. Adverse reactions from post-marketing experience are also listed. Adverse reactions are listed by System Organ Class (SOC) and within each frequency grouping the adverse reactions are presented in order of decreasing seriousness.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pregnancy: There are no data from the use of Pirfenidone in pregnant women. In animals placental transfer of pirfenidone and/or its metabolites occurs with the potential for accumulation of pirfenidone and/or its metabolites in amniotic fluid. At high doses (1000 mg/kg/day) rats exhibited prolongation of gestation and reduction in fetal viability. As a precautionary measure, it is preferable to avoid the use of Pirfenidone during pregnancy.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
There is limited clinical experience with overdose. Multiple doses of pirfenidone up to a dose of 4806 mg/day were administered as six 267 mg capsules three times daily to healthy adult volunteers over a 12-day dose escalation period. Adverse reactions were mild, transient, and consistent with the most frequently reported adverse reactions for pirfenidone.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Store in a cool and dry place, protected from light.একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।